Next Article in Journal
The Changing Face of Esophageal Cancer
Previous Article in Journal
Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value
Previous Article in Special Issue
Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin
Article Menu

Export Article

Open AccessReview
Cancers 2010, 2(2), 1354-1378; doi:10.3390/cancers2021354

The Nrf1 and Nrf2 Balance in Oxidative Stress Regulation and Androgen Signaling in Prostate Cancer Cells

1
Department of Pharmacology, Tulane University Medical Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA
2
Department of Urology, Tulane University Medical Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA
*
Author to whom correspondence should be addressed.
Received: 7 June 2010 / Revised: 18 June 2010 / Accepted: 21 June 2010 / Published: 21 June 2010
(This article belongs to the Special Issue Oxidative Stress and Cancer)
View Full-Text   |   Download PDF [579 KB, uploaded 21 June 2010]   |  

Abstract

Reactive oxygen species (ROS) signaling has recently sparked a surge of interest as being the molecular underpinning for cancer cell survival, but the precise mechanisms involved have not been completely elucidated. This review covers the possible roles of two ROS-induced transcription factors, Nrf1 and Nrf2, and the antioxidant proteins peroxiredoxin-1 (Prx-1) and Thioredoxin-1 (Txn-1) in modulating AR expression and signaling in aggressive prostate cancer (PCa) cells. In androgen independent (AI) C4-2B cells, in comparison to the parental androgen dependent (AD) LNCaP cells, we present evidence of high Nrf1 and Prx-1 expression and low Nrf2 expression in these aggressive PCa cells. Furthermore, in DHT treated C4-2B cells, increased expression of the p65 (active) isoform of Nrf1 correlated with enhanced AR transactivation. Our findings implicate a crucial balance of Nrf1 and Nrf2 signaling in regulating AR activity in AI-PCa cells. Here we will discuss how understanding the mechanisms by which oxidative stress may affect AR signaling may aid in developing novel therapies for AI-PCa. View Full-Text
Keywords: Nrf1 (NF-E2 related factor-1); Nrf2 (NF-E2 related factor-2); prostate cancer; oxidative stress; androgen independence; androgen deprivation therapy; reactive oxygen species (ROS); androgen receptor (AR); di-hydrotestosterone (DHT) Nrf1 (NF-E2 related factor-1); Nrf2 (NF-E2 related factor-2); prostate cancer; oxidative stress; androgen independence; androgen deprivation therapy; reactive oxygen species (ROS); androgen receptor (AR); di-hydrotestosterone (DHT)
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Schultz, M.A.; Abdel-Mageed, A.B.; Mondal, D. The Nrf1 and Nrf2 Balance in Oxidative Stress Regulation and Androgen Signaling in Prostate Cancer Cells. Cancers 2010, 2, 1354-1378.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top